Middle East Companion Animal Healthcare Market, by Therapeutics, 2018-2027

Growth Outlook

• The 2027 portion of the Middle East Companion Animal Healthcare Market, by Therapeutics, 2018 market is on a steady long-term growth path. Segment value stands at roughly USD 2943 Mn in 2026 and is projected to reach USD 3218 Mn by 2027 — a gain of about 9% over the forecast period, translating to a CAGR in the high single digits.
• What the regional split looks like (2026): Pharmaceuticals leads, holding roughly 58% of segment value — the single largest regional share. Vaccines is the second-largest contributor. Feed Additives make up the remainder, in descending order.
• By 2027, Pharmaceuticals alone is expected to reach USD 1848 Mn, with Vaccines at USD 698 Mn.

Market Dynamics

The Middle East region has a rapidly growing companion animal population, leading to a significant increase in demand for healthcare services. Companion animals, such as cats, dogs, and horses, are considered important members of the family in the Middle East and are provided with the best possible care. This has led to a rise in demand for high-quality therapeutics, making the Middle East Companion Animal Healthcare Market an attractive and lucrative market for industry players.

One of the key factors driving the growth of the Middle East Companion Animal Healthcare Market is the increasing awareness about pet health. Pet owners in the region are now more aware of the importance of preventive healthcare and are willing to spend more on quality therapeutics to keep their beloved animals healthy. This trend is also being supported by the availability of advanced and innovative therapeutics in the market, which is further fueling the demand for companion animal healthcare services in the region.

Another major factor contributing to the growth of this market is the rising incidence of chronic diseases among companion animals. Diseases like cancer, diabetes, and obesity are becoming increasingly common in pets, creating a need for effective therapeutics to manage and treat these conditions. As a result, there is a growing demand for specialized therapeutics that are specifically designed for companion animals, further boosting the market growth in the region.

Moreover, the Middle East region is witnessing a significant increase in pet ownership, particularly in urban areas. The rising disposable income and changing lifestyles are enabling people to afford and care for pets. This, in turn, has led to a surge in demand for companion animal healthcare services, including therapeutics, driving the market growth in the region.

In terms of therapeutics, the Middle East Companion Animal Healthcare Market is segmented into vaccines, antibiotics, anti-inflammatory, and parasiticides, among others. Vaccines hold a dominant share in the market, owing to the high prevalence of infectious diseases among companion animals. However, the demand for other therapeutics, such as antibiotics and anti-inflammatory drugs, is also rising due to the increasing incidence of chronic diseases.

Overall, the Middle East Companion Animal Healthcare Market is expected to continue its growth trajectory in the coming years, driven by the growing awareness about pet health, rising pet ownership, and increasing adoption of advanced therapeutics to manage and treat various diseases in companion animals.